Eden Research (LON:EDEN) Hits New 52-Week Low – Should You Sell?

Posted by Nicole Kennedy on Mar 4th, 2025

Eden Research plc (LON:EDEN – Get Free Report)’s share price reached a new 52-week low on Tuesday . The company traded as low as GBX 2.90 ($0.04) and last traded at GBX 3.10 ($0.04), with a volume of 1475285 shares changing hands. The stock had previously closed at GBX 3.15 ($0.04).

Eden Research Stock Performance

The firm has a market cap of £16.53 million, a price-to-earnings ratio of -10.86 and a beta of 0.92. The firm’s 50 day moving average is GBX 3.78 and its 200-day moving average is GBX 3.90. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80.

Insider Buying and Selling at Eden Research

In related news, insider Lykele van der Broek purchased 256,000 shares of the stock in a transaction on Thursday, February 6th. The shares were bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($13,013.09). Also, insider Alexander John Abrey purchased 167,947 shares of the company’s stock in a transaction dated Tuesday, March 4th. The stock was purchased at an average cost of GBX 3 ($0.04) per share, for a total transaction of £5,038.41 ($6,402.86). Insiders have purchased a total of 964,487 shares of company stock worth $3,690,001 over the last three months. Corporate insiders own 14.02% of the company’s stock.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.